OMIDOCS is a token associated with a groundbreaking longevity cocktail that combines two powerful components: Omipalisib and Doxycycline. This unique blend has demonstrated the potential to significantly extend lifespan, with studies showing an impressive 109% median lifespan increase in worms. The combination features a potent mTOR inhibitor and an FDA-approved antibiotic, which provide dose-dependent anti-inflammatory effects. This innovative approach aims to explore the synergistic mechanisms that could enhance lifespan extension beyond current boundaries. Developed by the Rapamycin Longevity Lab in collaboration with the Center for Healthy Longevity at the National University of Singapore, OMIDOCS represents a bold initiative in the field of longevity research. The token symbolizes a commitment to advancing healthspan and lifespan through scientific innovation. Its utility lies in supporting ongoing research and applications in longevity, making it a noteworthy addition to the evolving landscape of health and wellness solutions.